Cargando…

Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases

Case series Patient: — Final Diagnosis: Ulcerative colitis Symptoms: Diarrhea • hematochezia Medication: Tacrolimus Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Unusual setting of medical care BACKGROUND: Tacrolimus is reportedly effective for the treatment of refracto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamura, Haruna, Matsumoto, Satohiro, Nakamura, Noriyuki, Miyatani, Hiroyuki, Mashima, Hirosato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402855/ https://www.ncbi.nlm.nih.gov/pubmed/28411286 http://dx.doi.org/10.12659/AJCR.903339

Ejemplares similares

Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study
por: Matsumoto, Satohiro, et al.
Publicado: (2017)

Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis
por: Tsuboi, Rumiko, et al.
Publicado: (2018)

Efficacy of Combined Mesalazine Plus Corticosteroid Enemas for Diversion Colitis after Subtotal Colectomy for Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2016)

Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2021)

Tacrolimus Therapy for Three Patients with Elderly-Onset Ulcerative Colitis: Report of Three Cases
por: Kobayashi, Rumiko, et al.
Publicado: (2016)

Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2022)

Tacrolimus for the Treatment of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2015)

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus
por: Shimizu, Hiromichi, et al.
Publicado: (2021)

Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction
por: Miyatani, Hiroyuki, et al.
Publicado: (2018)

Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors
por: Miyatani, Hiroyuki, et al.
Publicado: (2019)

Clinical features and management of painless biliary type sphincter of Oddi dysfunction
por: Miyatani, Hiroyuki, et al.
Publicado: (2019)

Should Emergency Endoscopy be Performed in All Patients With Suspected Colonic Diverticular Hemorrhage?
por: Uehara, Takeshi, et al.
Publicado: (2017)

A case of gossypiboma diagnosed with transanal double-balloon enteroscopy
por: Ishii, Takehiro, et al.
Publicado: (2018)

Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study
por: Ito, Ayumi, et al.
Publicado: (2020)

Tacrolimus for Remission Induction and Maintenance Therapy in Patients with Ulcerative Colitis: A Retrospective Evaluation Study
por: Ito, Ayumi, et al.
Publicado: (2016)

Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
por: Numa, Keijiro, et al.
Publicado: (2023)

Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan
por: Yanagi, Tadahiro, et al.
Publicado: (2019)

Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
por: Nakata, Satoshi, et al.
Publicado: (2022)

Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients
por: Cha, Na, et al.
Publicado: (2022)

The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients
por: Hiraoka, Sakiko, et al.
Publicado: (2015)

CYP3A5 Genotype as a Potential Pharmacodynamic Biomarker for Tacrolimus Therapy in Ulcerative Colitis in Japanese Patients
por: Yamamoto, Yuki, et al.
Publicado: (2020)

Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction
por: Nishida, Yu, et al.
Publicado: (2019)

Tacrolimus Therapy for Ulcerative Colitis-Associated Post-Colectomy Enteritis
por: Rush, Barret, et al.
Publicado: (2014)

Tacrolimus in pediatric ulcerative colitis: does it have a role?
por: Kim, Seung
Publicado: (2019)

3D printed tacrolimus suppositories for the treatment of ulcerative colitis
por: Seoane-Viaño, Iria, et al.
Publicado: (2021)

Development and Improvement of Simple Colonic Mucosal Ulcer during Treatment of Severe Ulcerative Colitis with Tacrolimus
por: Ito, Ayumi, et al.
Publicado: (2017)

Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients
por: Kitayama, Moto, et al.
Publicado: (2020)

An interaction between tacrolimus and pristinamycin resulting in an elevated tacrolimus level
por: Tehan, Jane V., et al.
Publicado: (2011)

Retrospective investigation of tacrolimus combined with an anti‐tumor necrosis factorα antibody as remission induction therapy for refractory ulcerative colitis: Efficacy, safety, and relapse rate
por: Ito, Ayumi, et al.
Publicado: (2019)

Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis
por: Liu, Yi-Juan, et al.
Publicado: (2018)

Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2020)

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report
por: Rieker, Lisanne, et al.
Publicado: (2022)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018)

Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
por: Matsumoto, Satohiro, et al.
Publicado: (2020)

Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn’s Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
por: Matsumoto, Satohiro, et al.
Publicado: (2023)

Two Cases of Severe Ulcerative Colitis with Colonic Dilatation Resolved with Tacrolimus Therapy
por: Hayashi, Ryohei, et al.
Publicado: (2015)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Utility of endoscopic ultrasonography-guided fine-needle biopsy (EUS-FNB) for diagnosing small subepithelial lesions (< 20 mm)
por: Sekine, Masanari, et al.
Publicado: (2021)

Successful induction of granulomatosis with polyangiitis with tacrolimus
por: Ramachandran, R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i4u1027l1r7l9f9mfoka8q3aqj